Hypofractionated-Intensity Modulated Radiation Therapy (Hypo-IMRT) and Temozolomide (TMZ) With and Without Bevacizumab (BEV) for Glioblastoma Multiforme (GBM): A Comparison of 2 Prospective Phase 2 Trials Meeting Abstract (Web of Science)

cited authors

  • Carlson, J. A.; Reddy, K.; Gaspar, L. E.; Ney, D.; Kavanagh, B. D.; Damek, D.; Lillehei, K. O.; Chen, C.

publication date

  • September 1, 2014

webpage

published in

start page

  • S284

end page

  • S284

volume

  • 90